# I05 — PYDANTIC_CONDITIONAL_CRITIC — COMMON_TRANSCRIPT T2

## INPUT

Message utilisateur courant VERBATIM :

> Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC, mais je veux garder les analyses baseline-only si elles restent valides.

Conversation précédente VERBATIM :

> I05:T0 | USER : On a une IRM avant et après radiochimiothérapie. Je veux savoir si ça change et si ça prédit la récidive. Ceux qui n'ont pas la seconde, on en fait quoi ?
> I05:R1 | USER : Je me suis mal exprimé : la récidive n'est pas le critère principal, c'est la réponse pathologique. La récidive sera exploratoire.

## NATIVE OUTPUT

Artefact : `experiments/semantic-engine-comparison/results/common-contract-ablation-02/native-outputs/common-transcript-i05-t2-pydantic-conditional-critic.json`

```json
{
  "criticOutput": {
    "correctedState": {
      "ambiguities": [
        {
          "ambiguityId": "amb_second_irm_handling",
          "content": "How to handle patients missing the second MRI for baseline-only analyses versus delta ADC calculations.",
          "decisionImpact": "Whether to include baseline-only data in a combined model or separate cohort, and how to define validity criteria for these analyses.",
          "epistemicStatus": "AMBIGUOUS",
          "interpretations": [
            "Exclude patients entirely from delta-based analyses but keep them for baseline-only evaluations.",
            "Impute missing second MRI data or use a secondary model."
          ],
          "provenanceTurnIds": [
            "I05:T0",
            "I05:R2"
          ]
        }
      ],
      "clarificationCandidates": [
        {
          "blocking": false,
          "clarificationId": "cl_baseline_validity",
          "decisionImpact": "Defining exact inclusion and validation criteria for baseline-only MRI analyses when the follow-up MRI is missing.",
          "priority": "MEDIUM",
          "question": "Quels critères précis retenez-vous pour valider les analyses basées uniquement sur la baseline chez les patients sans seconde IRM ?",
          "targetIds": [
            "amb_second_irm_handling"
          ]
        }
      ],
      "contextualScientificCandidates": [],
      "contradictions": [],
      "conversationTurns": [
        {
          "content": "On a une IRM avant et après radiochimiothérapie. Je veux savoir si ça change et si ça prédit la récidive. Ceux qui n'ont pas la seconde, on en fait quoi ?",
          "role": "USER",
          "turnId": "I05:T0"
        },
        {
          "content": "Je me suis mal exprimé : la récidive n'est pas le critère principal, c'est la réponse pathologique. La récidive sera exploratoire.",
          "role": "USER",
          "turnId": "I05:R1"
        },
        {
          "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC, mais je veux garder les analyses baseline-only si elles restent valides.",
          "role": "USER",
          "turnId": "I05:R2"
        }
      ],
      "correctionsAndSupersessions": [
        {
          "correctionId": "corr_primary_endpoint",
          "currentContent": "La réponse pathologique est le critère principal.",
          "disposition": "SUPERSEDED",
          "previousContent": "La récidive est le critère principal.",
          "provenanceTurnIds": [
            "I05:R1"
          ]
        }
      ],
      "explicitUserStatements": [
        {
          "basis": null,
          "content": "On a une IRM avant et après radiochimiothérapie.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_mri_timing",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "scientificRole": "PHENOMENON",
          "sourceText": "On a une IRM avant et après radiochimiothérapie.",
          "temporalContext": "BEFORE_AND_AFTER_CRT"
        },
        {
          "basis": null,
          "content": "Je veux savoir si ça change et si ça prédit la récidive.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_initial_goal",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "scientificRole": "SCIENTIFIC_GOAL",
          "sourceText": "Je veux savoir si ça change et si ça prédit la récidive.",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "content": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_missing_second_mri_question",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "scientificRole": "PROJECT_VARIABLE",
          "sourceText": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "content": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_primary_endpoint_pathologic_response",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "scientificRole": "ENDPOINT",
          "sourceText": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "content": "La récidive sera exploratoire.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_recurrence_exploratory",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "scientificRole": "ENDPOINT",
          "sourceText": "La récidive sera exploratoire.",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_delta_adc_impossible",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R2"
          ],
          "scientificRole": "METHOD_MEASUREMENT_DEFINITION",
          "sourceText": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "content": "je veux garder les analyses baseline-only si elles restent valides.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "st_keep_baseline_only",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R2"
          ],
          "scientificRole": "PROJECT_VARIABLE",
          "sourceText": "je veux garder les analyses baseline-only si elles restent valides.",
          "temporalContext": "UNKNOWN"
        }
      ],
      "inferredContext": [],
      "missingInformation": [
        {
          "blocking": false,
          "content": "Validity criteria for baseline-only analyses when follow-up MRI is absent.",
          "decisionImpact": "MEDIUM",
          "missingId": "miss_baseline_validity_criteria",
          "owner": "USER",
          "priority": "MEDIUM",
          "provenanceTurnIds": [
            "I05:R2"
          ]
        }
      ],
      "negationsAndConstraints": [],
      "normalizedUnderstanding": "The user initially asked about evaluating longitudinal MRI changes before and after chemoradiotherapy to predict recurrence, but subsequently corrected the primary endpoint to pathologic response, designating recurrence as exploratory. For patients missing the second MRI, delta ADC cannot be calculated, but the user wishes to retain baseline-only analyses provided they remain valid.",
      "objects": [
        {
          "basis": null,
          "content": "IRM avant et après radiochimiothérapie",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "obj_mri_crt",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "scientificRole": "PHENOMENON",
          "sourceText": "IRM avant et après radiochimiothérapie",
          "temporalContext": "BEFORE_AND_AFTER_CRT"
        },
        {
          "basis": null,
          "content": "delta ADC",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "obj_delta_adc",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R2"
          ],
          "scientificRole": "OBSERVABLE_PROPERTY",
          "sourceText": "delta ADC",
          "temporalContext": "LONGITUDINAL"
        },
        {
          "basis": null,
          "content": "réponse pathologique",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "obj_pathologic_response",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "scientificRole": "ENDPOINT",
          "sourceText": "réponse pathologique",
          "temporalContext": "POST_TREATMENT"
        },
        {
          "basis": null,
          "content": "récidive",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "itemId": "obj_recurrence",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "provenanceTurnIds": [
            "I05:T0",
            "I05:R1"
          ],
          "scientificRole": "ENDPOINT",
          "sourceText": "récidive",
          "temporalContext": "FOLLOW_UP"
        }
      ],
      "originalRequest": "On a une IRM avant et après radiochimiothérapie. Je veux savoir si ça change et si ça prédit la récidive. Ceux qui n'ont pas la seconde, on en fait quoi ?",
      "ownershipAndEpistemicState": [
        {
          "content": "On a une IRM avant et après radiochimiothérapie.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "statementId": "st_mri_timing"
        },
        {
          "content": "Je veux savoir si ça change et si ça prédit la récidive.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "statementId": "st_initial_goal"
        },
        {
          "content": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:T0"
          ],
          "statementId": "st_missing_second_mri_question"
        },
        {
          "content": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "statementId": "st_primary_endpoint_pathologic_response"
        },
        {
          "content": "La récidive sera exploratoire.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "statementId": "st_recurrence_exploratory"
        },
        {
          "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:R2"
          ],
          "statementId": "st_delta_adc_impossible"
        },
        {
          "content": "je veux garder les analyses baseline-only si elles restent valides.",
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "owner": "USER",
          "provenanceTurnIds": [
            "I05:R2"
          ],
          "statementId": "st_keep_baseline_only"
        }
      ],
      "relations": [
        {
          "basis": null,
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "object": "obj_pathologic_response",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "predicate": "isPrimaryEndpointFor",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "relationId": "rel_primary_endpoint",
          "sourceText": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
          "subject": "obj_pathologic_response",
          "temporalContext": "UNKNOWN"
        },
        {
          "basis": null,
          "epistemicStatus": "EXPLICIT_USER_STATED",
          "object": "obj_recurrence",
          "ownership": "USER",
          "polarity": "AFFIRMED",
          "predicate": "isExploratoryEndpointFor",
          "provenanceTurnIds": [
            "I05:R1"
          ],
          "relationId": "rel_exploratory_endpoint",
          "sourceText": "La récidive sera exploratoire.",
          "subject": "obj_recurrence",
          "temporalContext": "UNKNOWN"
        }
      ],
      "scientificGoal": "Evaluate longitudinal MRI changes before and after chemoradiotherapy to predict pathologic response (primary endpoint) and recurrence (exploratory endpoint), and handle patients missing the follow-up MRI via baseline-only analyses if valid.",
      "temporalModel": [],
      "unknowns": []
    },
    "rationale": "The current state accurately reflects the conversation turns, explicit user statements, supersessions, and ambiguity definitions without any fidelity or structural errors.",
    "verdict": "ACCEPT"
  },
  "criticTrigger": {
    "reasons": [
      "AMBIGUITIES_PRESENT",
      "CORRECTIONS_OR_SUPERSESSIONS_PRESENT"
    ],
    "required": true
  },
  "firstOutput": {
    "ambiguities": [
      {
        "ambiguityId": "amb_second_irm_handling",
        "content": "How to handle patients missing the second MRI for baseline-only analyses versus delta ADC calculations.",
        "decisionImpact": "Whether to include baseline-only data in a combined model or separate cohort, and how to define validity criteria for these analyses.",
        "epistemicStatus": "AMBIGUOUS",
        "interpretations": [
          "Exclude patients entirely from delta-based analyses but keep them for baseline-only evaluations.",
          "Impute missing second MRI data or use a secondary model."
        ],
        "provenanceTurnIds": [
          "I05:T0",
          "I05:R2"
        ]
      }
    ],
    "clarificationCandidates": [
      {
        "blocking": false,
        "clarificationId": "cl_baseline_validity",
        "decisionImpact": "Defining exact inclusion and validation criteria for baseline-only MRI analyses when the follow-up MRI is missing.",
        "priority": "MEDIUM",
        "question": "Quels critères précis retenez-vous pour valider les analyses basées uniquement sur la baseline chez les patients sans seconde IRM ?",
        "targetIds": [
          "amb_second_irm_handling"
        ]
      }
    ],
    "contextualScientificCandidates": [],
    "contradictions": [],
    "conversationTurns": [
      {
        "content": "On a une IRM avant et après radiochimiothérapie. Je veux savoir si ça change et si ça prédit la récidive. Ceux qui n'ont pas la seconde, on en fait quoi ?",
        "role": "USER",
        "turnId": "I05:T0"
      },
      {
        "content": "Je me suis mal exprimé : la récidive n'est pas le critère principal, c'est la réponse pathologique. La récidive sera exploratoire.",
        "role": "USER",
        "turnId": "I05:R1"
      },
      {
        "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC, mais je veux garder les analyses baseline-only si elles restent valides.",
        "role": "USER",
        "turnId": "I05:R2"
      }
    ],
    "correctionsAndSupersessions": [
      {
        "correctionId": "corr_primary_endpoint",
        "currentContent": "La réponse pathologique est le critère principal.",
        "disposition": "SUPERSEDED",
        "previousContent": "La récidive est le critère principal.",
        "provenanceTurnIds": [
          "I05:R1"
        ]
      }
    ],
    "explicitUserStatements": [
      {
        "basis": null,
        "content": "On a une IRM avant et après radiochimiothérapie.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_mri_timing",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:T0"
        ],
        "scientificRole": "PHENOMENON",
        "sourceText": "On a une IRM avant et après radiochimiothérapie.",
        "temporalContext": "BEFORE_AND_AFTER_CRT"
      },
      {
        "basis": null,
        "content": "Je veux savoir si ça change et si ça prédit la récidive.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_initial_goal",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:T0"
        ],
        "scientificRole": "SCIENTIFIC_GOAL",
        "sourceText": "Je veux savoir si ça change et si ça prédit la récidive.",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "content": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_missing_second_mri_question",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:T0"
        ],
        "scientificRole": "PROJECT_VARIABLE",
        "sourceText": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "content": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_primary_endpoint_pathologic_response",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R1"
        ],
        "scientificRole": "ENDPOINT",
        "sourceText": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "content": "La récidive sera exploratoire.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_recurrence_exploratory",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R1"
        ],
        "scientificRole": "ENDPOINT",
        "sourceText": "La récidive sera exploratoire.",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_delta_adc_impossible",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R2"
        ],
        "scientificRole": "METHOD_MEASUREMENT_DEFINITION",
        "sourceText": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "content": "je veux garder les analyses baseline-only si elles restent valides.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "st_keep_baseline_only",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R2"
        ],
        "scientificRole": "PROJECT_VARIABLE",
        "sourceText": "je veux garder les analyses baseline-only si elles restent valides.",
        "temporalContext": "UNKNOWN"
      }
    ],
    "inferredContext": [],
    "missingInformation": [
      {
        "blocking": false,
        "content": "Validity criteria for baseline-only analyses when follow-up MRI is absent.",
        "decisionImpact": "MEDIUM",
        "missingId": "miss_baseline_validity_criteria",
        "owner": "USER",
        "priority": "MEDIUM",
        "provenanceTurnIds": [
          "I05:R2"
        ]
      }
    ],
    "negationsAndConstraints": [],
    "normalizedUnderstanding": "The user initially asked about evaluating longitudinal MRI changes before and after chemoradiotherapy to predict recurrence, but subsequently corrected the primary endpoint to pathologic response, designating recurrence as exploratory. For patients missing the second MRI, delta ADC cannot be calculated, but the user wishes to retain baseline-only analyses provided they remain valid.",
    "objects": [
      {
        "basis": null,
        "content": "IRM avant et après radiochimiothérapie",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_mri_crt",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:T0"
        ],
        "scientificRole": "PHENOMENON",
        "sourceText": "IRM avant et après radiochimiothérapie",
        "temporalContext": "BEFORE_AND_AFTER_CRT"
      },
      {
        "basis": null,
        "content": "delta ADC",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_delta_adc",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R2"
        ],
        "scientificRole": "OBSERVABLE_PROPERTY",
        "sourceText": "delta ADC",
        "temporalContext": "LONGITUDINAL"
      },
      {
        "basis": null,
        "content": "réponse pathologique",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_pathologic_response",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:R1"
        ],
        "scientificRole": "ENDPOINT",
        "sourceText": "réponse pathologique",
        "temporalContext": "POST_TREATMENT"
      },
      {
        "basis": null,
        "content": "récidive",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "itemId": "obj_recurrence",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "provenanceTurnIds": [
          "I05:T0",
          "I05:R1"
        ],
        "scientificRole": "ENDPOINT",
        "sourceText": "récidive",
        "temporalContext": "FOLLOW_UP"
      }
    ],
    "originalRequest": "On a une IRM avant et après radiochimiothérapie. Je veux savoir si ça change et si ça prédit la récidive. Ceux qui n'ont pas la seconde, on en fait quoi ?",
    "ownershipAndEpistemicState": [
      {
        "content": "On a une IRM avant et après radiochimiothérapie.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_mri_timing"
      },
      {
        "content": "Je veux savoir si ça change et si ça prédit la récidive.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_initial_goal"
      },
      {
        "content": "Ceux qui n'ont pas la seconde, on en fait quoi ?",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_missing_second_mri_question"
      },
      {
        "content": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_primary_endpoint_pathologic_response"
      },
      {
        "content": "La récidive sera exploratoire.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_recurrence_exploratory"
      },
      {
        "content": "Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_delta_adc_impossible"
      },
      {
        "content": "je veux garder les analyses baseline-only si elles restent valides.",
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "owner": "USER",
        "provenanceTurnIds": [],
        "statementId": "st_keep_baseline_only"
      }
    ],
    "relations": [
      {
        "basis": null,
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "obj_pathologic_response",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "isPrimaryEndpointFor",
        "provenanceTurnIds": [
          "I05:R1"
        ],
        "relationId": "rel_primary_endpoint",
        "sourceText": "la récidive n'est pas le critère principal, c'est la réponse pathologique.",
        "subject": "obj_pathologic_response",
        "temporalContext": "UNKNOWN"
      },
      {
        "basis": null,
        "epistemicStatus": "EXPLICIT_USER_STATED",
        "object": "obj_recurrence",
        "ownership": "USER",
        "polarity": "AFFIRMED",
        "predicate": "isExploratoryEndpointFor",
        "provenanceTurnIds": [
          "I05:R1"
        ],
        "relationId": "rel_exploratory_endpoint",
        "sourceText": "La récidive sera exploratoire.",
        "subject": "obj_recurrence",
        "temporalContext": "UNKNOWN"
      }
    ],
    "scientificGoal": "Evaluate longitudinal MRI changes before and after chemoradiotherapy to predict pathologic response (primary endpoint) and recurrence (exploratory endpoint), and handle patients missing the follow-up MRI via baseline-only analyses if valid.",
    "temporalModel": [],
    "unknowns": []
  }
}
```

## STRUCTURED CONTRACT STATUS

- provider status : `SUCCESS`
- parsing status : `PARSED_AND_VALIDATED`
- structured contract conformance : `PASS`
- scientific semantic evaluability : `EVALUABLE`
- evaluation mode : `DETERMINISTIC_COMMON_STATE_PROJECTION`
- native raw output persisted : `false`

## SCIENTIFIC INTERPRETATION

### COMPRÉHENSION GLOBALE

The user initially asked about evaluating longitudinal MRI changes before and after chemoradiotherapy to predict recurrence, but subsequently corrected the primary endpoint to pathologic response, designating recurrence as exploratory. For patients missing the second MRI, delta ADC cannot be calculated, but the user wishes to retain baseline-only analyses provided they remain valid.

Objectif scientifique produit :

Evaluate longitudinal MRI changes before and after chemoradiotherapy to predict pathologic response (primary endpoint) and recurrence (exploratory endpoint), and handle patients missing the follow-up MRI via baseline-only analyses if valid.

### EXPLICITEMENT DIT PAR LE CHERCHEUR

- content=On a une IRM avant et après radiochimiothérapie. | scientificRole=PHENOMENON | polarity=AFFIRMED | temporalContext=BEFORE_AND_AFTER_CRT | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=On a une IRM avant et après radiochimiothérapie. | provenanceTurnIds=["I05:T0"]
- content=Je veux savoir si ça change et si ça prédit la récidive. | scientificRole=SCIENTIFIC_GOAL | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Je veux savoir si ça change et si ça prédit la récidive. | provenanceTurnIds=["I05:T0"]
- content=Ceux qui n'ont pas la seconde, on en fait quoi ? | scientificRole=PROJECT_VARIABLE | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Ceux qui n'ont pas la seconde, on en fait quoi ? | provenanceTurnIds=["I05:T0"]
- content=la récidive n'est pas le critère principal, c'est la réponse pathologique. | scientificRole=ENDPOINT | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=la récidive n'est pas le critère principal, c'est la réponse pathologique. | provenanceTurnIds=["I05:R1"]
- content=La récidive sera exploratoire. | scientificRole=ENDPOINT | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=La récidive sera exploratoire. | provenanceTurnIds=["I05:R1"]
- content=Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC | scientificRole=METHOD_MEASUREMENT_DEFINITION | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC | provenanceTurnIds=["I05:R2"]
- content=je veux garder les analyses baseline-only si elles restent valides. | scientificRole=PROJECT_VARIABLE | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=je veux garder les analyses baseline-only si elles restent valides. | provenanceTurnIds=["I05:R2"]

### RELATIONS COMPRISES

- subject=obj_pathologic_response | predicate=isPrimaryEndpointFor | object=obj_pathologic_response | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=la récidive n'est pas le critère principal, c'est la réponse pathologique. | provenanceTurnIds=["I05:R1"]
- subject=obj_recurrence | predicate=isExploratoryEndpointFor | object=obj_recurrence | polarity=AFFIRMED | temporalContext=UNKNOWN | epistemicStatus=EXPLICIT_USER_STATED | ownership=USER | sourceText=La récidive sera exploratoire. | provenanceTurnIds=["I05:R1"]

### CONTEXTE INFÉRÉ

- Aucun élément produit.

### CANDIDATS SCIENTIFIQUES CONTEXTUELS

- Aucun élément produit.

### NÉGATIONS / CONTRAINTES

- Aucun élément produit.

### TEMPORALITÉ

- Aucun élément produit.

### AMBIGUÏTÉS

- content=How to handle patients missing the second MRI for baseline-only analyses versus delta ADC calculations. | epistemicStatus=AMBIGUOUS | decisionImpact=Whether to include baseline-only data in a combined model or separate cohort, and how to define validity criteria for these analyses. | provenanceTurnIds=["I05:T0", "I05:R2"] | interpretations=["Exclude patients entirely from delta-based analyses but keep them for baseline-only evaluations.", "Impute missing second MRI data or use a secondary model."]

### INFORMATIONS MANQUANTES

- content=Validity criteria for baseline-only analyses when follow-up MRI is absent. | owner=USER | priority=MEDIUM | blocking=non | decisionImpact=MEDIUM | provenanceTurnIds=["I05:R2"]

### INCONNUES

- Aucun élément produit.

### CORRECTIONS / SUPERSESSIONS

- previousContent=La récidive est le critère principal. | currentContent=La réponse pathologique est le critère principal. | provenanceTurnIds=["I05:R1"] | disposition=SUPERSEDED

### OWNERSHIP / STATUT ÉPISTÉMIQUE

- content=On a une IRM avant et après radiochimiothérapie. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:T0"]
- content=Je veux savoir si ça change et si ça prédit la récidive. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:T0"]
- content=Ceux qui n'ont pas la seconde, on en fait quoi ? | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:T0"]
- content=la récidive n'est pas le critère principal, c'est la réponse pathologique. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:R1"]
- content=La récidive sera exploratoire. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:R1"]
- content=Pour ceux qui n'ont pas la seconde IRM, on ne peut pas calculer le delta ADC | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:R2"]
- content=je veux garder les analyses baseline-only si elles restent valides. | epistemicStatus=EXPLICIT_USER_STATED | owner=USER | provenanceTurnIds=["I05:R2"]

### QUESTIONS DE CLARIFICATION CANDIDATES

- question=Quels critères précis retenez-vous pour valider les analyses basées uniquement sur la baseline chez les patients sans seconde IRM ? | priority=MEDIUM | blocking=non | decisionImpact=Defining exact inclusion and validation criteria for baseline-only MRI analyses when the follow-up MRI is missing. | targetIds=["amb_second_irm_handling"]

## MISSING STRUCTURAL GUARANTEES

- EXACT_PROVIDER_RAW_TEXT_NOT_PERSISTED; STRUCTURED_NATIVE_ARTIFACT_AVAILABLE

_Vue locale déterministe. Aucun appel LLM d’interprétation sémantique post-hoc._
